Viela Bio
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Business Model:
Revenue: $240.9M
Employees: 51-200
Industries / Tags:
Detailed Viela Bio Information
Viela Bio was acquired by
Horizon Therapeutics.
The acquisition happend on 2021-02-01.
Details of the transaction were not public
Acquirer
Geographic Data
Address: One MedImmune Way
City: Gaithersburg
State: MD
Zip: 20878
Country: US
Financial Info
Stage:
series b
Raised Last:
$75M
Raised Total:$357M
Social
Metrics
2,026,363Website Global Rank
3,730Website Monthly Traffic
Twitter Followers
Description
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Contact Phone:
+12405580038
Contact Email:
Viela Bio went public on 10/2/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/2/2019
IPO Valuation:
$942M
Ticker Symbol:
VIE
IPO Price:
$19/share
Amount Raised:
$150M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
